Lorraine Webster

Lorraine is a highly motivated professional in the field of regulatory toxicology and pharmaceuticals, equipped with extensive practical experience in drug development.

Throughout her impressive career spanning over three decades, she has made valuable contributions to the success of renowned international pharmaceutical and biotechnology companies.

In addition, Lorraine is a respected scientist, having led a translational oncology research laboratory and published over 70 papers. She possesses a deep commitment to supporting the biotechnology industry and clinical research organizations, utilizing her expertise to devise effective preclinical and early clinical strategies that accelerate the progression of biologicals and small molecules from concept to the clinic.

Lorraine’s specific areas of expertise encompass the implementation of regulatory-compliant (GLP) toxicology programs, the design of preclinical proof-of-concept pharmacology studies, the facilitation of human research ethics committee submissions, and providing pharmacokinetics/pharmacodynamics support for clinical trials.